48 results
Hypereosinophilia and Hypereosinophilic Syndrome

 • Secondary Hypereosinophilic Syndrome
 • Clinically Relevant HES Variants
 • When to
Hypereosinophilic Syndrome • Clinically ... and Treatment Algorithm ... Syndrome #HES #Hematology ... eosinophils #diagnosis #management ... #algorithm
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #medications #table ... decisionaid #cardiology #hematology ... #warfarin #dosing
Summary of types of haemolytic anaemia. Visit gramproject.com for more medical diagrams, tables and flowcharts for
medical diagrams, tables ... #diagnosis #clinical ... #management #differential ... #algorithm #anaemia ... #haematology
Algorithm for the Evaluation and Management of Sickle Cell Crises
Clinical Manifestations and Management

#Diagnosis #Management #Hematology #SickleCell
Algorithm for the ... Evaluation and Management ... Sickle Cell Crises Clinical ... #Hematology #SickleCell ... Manifestations #Workup #Algorithm
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
VTE in selected clinical ... prophylaxis #VTE #DVT #dosing ... #Medications #management ... #pharmacology #table
Our approach to the diagnosis and initial management of patients with suspected HIT. Our approach is
diagnosis and initial management ... based primarily on clinical ... imprecise, and complemented ... #Hematology #HIT ... Thrombocytopenia #Algorithm
Suggested algorithm for follow-up of monoclonal gammopathy of undetermined significance (MGUS)
Mayo Clinic Risk Stratification Model. CBC,
Suggested algorithm ... significance (MGUS) Mayo Clinic ... MGUS #Followup #algorithm ... #diagnosis #management ... #hematology #multiplemyeloma
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... 40, F:M 9:1 • Clinical ... 80% - Low complement ... Usual therapeutic management ... #Summary #rheumatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for appropriate dosing ... Malignancy #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... 90% - Low complement ... sle #comparison #table ... #rheumatology # ... diagnosis #management